Blood · 2005 · 110 citations · 19 references
Life SciencesBiochemistryGeneticsHuman GeneticsMolecular PathologyClinical ProteomicsBombay Blood GroupBombay PhenotypeDisease Mechanism ElucidationPlasma ProteomicsPrimary ProteolysisProteolysis Products
ABO blood group is an important determinant of plasma von Willebrand factor antigen (VWF:Ag) levels, with lower levels in group O. Previous reports have suggested that ABO(H) sugars affect the susceptibility of VWF to ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type-1 repeats-13) cleavage. To further test this hypothesis, we collected plasma from individuals with the rare Bombay blood group. VWF:Ag levels were significantly lower in Bombay patients (median, 0.69 IU/mL) than in groups AB, A, or B (P < .05) and lower than in group O individuals (median, 0.82 IU/mL). Susceptibility of purified VWF fractions to recombinant ADAMTS13 cleavage, assessed using VWF collagen-binding assay (VWF:CB), was increased in Bombays compared with either group O or AB. Increasing urea concentration (0.5 to 2 M) increased the cleavage rate for each blood group but eliminated the differences between groups. We conclude that reduction in the number of terminal sugars on N-linked glycan increases susceptibility of globular VWF to ADAMTS13 proteolysis and is associated with reduced plasma VWF:Ag and VWF:CB levels.
19
The effect of ABO blood group on the diagnosis of von Willebrand disease
JC Gill, J Endres-Brooks, PJ Bauer et al. · Blood · 1987 · 939 citations · Full text
Medicine, Hematology, Pathology +14
Proteolytic inactivation of ADAMTS13 by thrombin and plasmin
James T. B. Crawley, Jonathan Lam, James B. Rance et al. · Blood · 2004 · 239 citations · Full text